Connecticut Moves Closer to Approving Medical Marijuana for EDS

Connecticut Moves Closer to Approving Medical Marijuana for EDS

A panel of physicians has voted in favor of adding Ehlers-Danlos syndrome (EDS) to the list of conditions that are eligible for treatment with medical marijuana in Connecticut.

According to an Associated Press story, the vote took place Sept. 27 and the recommendation was officially accepted by Michelle Seagull, commissioner of the Connecticut Department of Consumer Protection.

In addition to EDS, the board also voted in favor of allowing medical marijuana treatment for adults who experience chronic pain that lasts for six months or longer, and that is associated with a specific underlying chronic condition.

In contrast, the board voted against adding night terrors (episodes of screaming and/or intense fear while asleep) or parasomnia (a blanket term related to any condition that interferes with sleep apart from sleep apnea) to the list of approved conditions for medical marijuana.

Following the physician panel vote, the final decision on including EDS and chronic pain to the list of approved conditions will be decided by the Regulations Review Committee of Connecticut’s General Assembly. A vote from that legislative panel is expected in the coming weeks.

Marijuana is a broad term that typically refers to the dried cannabis plant, though it also is used broadly in reference to derivatives of the plant. In addition to the well-known psychoactive effects of marijuana consumption, the plant, its derivatives, and compounds isolated from it are currently undergoing a surge of scientific exploration for its possible medicinal purposes.

Of particular note to the aforementioned conditions, there is a growing body of evidence that marijuana may have pain-relieving effects.

Marijuana is currently illegal in the United States at the federal level; however, for the past decade or so, many states have legalized it for medicinal and/or recreational purposes.

If EDS and chronic pain are approved by Connecticut’s General Assembly, they will join 31 other conditions for which medical marijuana is approved for adults in the state.

According to Connecticut’s Department of Consumer Protection website, almost 40,000 people are enrolled in Connecticut’s medical marijuana program. Furthermore, in the state, there are nearly 1,200 physicians and advanced practice registered nurses (APRNs) registered who can certify patients; there also are 14 medical marijuana dispensaries.

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
Total Posts: 1
Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
×
Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
Latest Posts
  • medical marijuana
  • spontaneous renal artery dissection
  • early EDS diagnosis
  • Edviso FDA NDA

Leave a Comment

Your email address will not be published. Required fields are marked *